Influence of Alternative Tubulin Inhibitors on the Potency of Epirubicin-Immunochemotherapeutic Synthesized with an Ultra Violet Light-Activated Intermediate
Cancer and Clinical Oncology · 2012
DOI: 10.5539/cco.v1n2p49 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer and Clinical Oncology, 2012. Verfasst von C P Coyne und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Sciences, College of Veterinary Medicine, Mississippi State University, USA. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Basic Sciences, College of Veterinary Medicine, Mississippi State University, USA.
- College of Veterinary Medicine, Mississippi State University, USA.
Förderung
- NIH HHS
Zitieren
APA
Coyne, C. P., Jones, T., & Bear, R. (2012). Influence of Alternative Tubulin Inhibitors on the Potency of Epirubicin-Immunochemotherapeutic Synthesized with an Ultra Violet Light-Activated Intermediate. Cancer and Clinical Oncology. https://doi.org/10.5539/cco.v1n2p49
Vancouver
Coyne CP, Jones T, Bear R. Influence of Alternative Tubulin Inhibitors on the Potency of Epirubicin-Immunochemotherapeutic Synthesized with an Ultra Violet Light-Activated Intermediate. Cancer and Clinical Oncology. 2012. doi:10.5539/cco.v1n2p49
BibTeX
@article{Coyne2012,
author = {Coyne, C P and Jones, Toni and Bear, Ryan},
title = {Influence of Alternative Tubulin Inhibitors on the Potency of Epirubicin-Immunochemotherapeutic Synthesized with an Ultra Violet Light-Activated Intermediate},
journal = {Cancer and Clinical Oncology},
year = {2012},
doi = {10.5539/cco.v1n2p49}
}
EUVIMED